Cargando…

(99m)Tc-HYNIC-(tricine/EDDA)-FROP peptide for MCF-7 breast tumor targeting and imaging

BACKGROUND: Breast cancer is the most common malignancy among women in the world. Development of novel tumor-specific radiopharmaceuticals for early breast tumor diagnosis is highly desirable. In this study we developed (99m)Tc-HYNIC-(tricine/EDDA)-Lys-FROP peptide with the ability of specific bindi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahmadpour, Sajjad, Noaparast, Zohreh, Abedi, Seyed Mohammad, Hosseinimehr, Seyed Jalal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5817723/ https://www.ncbi.nlm.nih.gov/pubmed/29455647 http://dx.doi.org/10.1186/s12929-018-0420-x

Ejemplares similares

(99m)Tc-radiolabeled GE11-modified peptide for ovarian tumor targeting
por: Rahmanian, Najmeh, et al.
Publicado: (2017)

A (99m)Tc-tricine-HYNIC-labeled Peptide Targeting the Melanocortin-1 Receptor for Melanoma Imaging
por: Shamshirian, Danial, et al.
Publicado: (2016)

The New Radiolabeled Peptide (99m)TcEDDA/HYNIC-TOC: Is It a Feasible Choice for Diagnosing Gastroenteropancreatic NETs?
por: Gherghe, Mirela, et al.
Publicado: (2022)

The Diagnostic Efficiency of 99mTc-EDDA/HYNIC-Octreotate SPECT-CT in Comparison with 111In-Pentetrotide in the Detection of Neuroendocrine Tumours
por: Koçyiğit Deveci, Emel, et al.
Publicado: (2013)

Evaluation of [(99m)Tc][Tc-HYNIC/EDDA]-Tyr as a target for metabolic tumor imaging in B16F10 melanoma tumor
por: Yaghoubi Mogadam, Hemat, et al.
Publicado: (2022)

(99m)Tc-EDDA/HYNIC-TOC is a New Opportunity in Neuroendocrine Tumors of the Lung (and in other Malignant and Benign Pulmonary Diseases)
por: Briganti, Vittorio, et al.
Publicado: (2020)

Glucagon-like peptide-1 receptor imaging with [Lys(40)(Ahx-HYNIC-(99m)Tc/EDDA)NH(2)]-exendin-4 for the detection of insulinoma
por: Sowa-Staszczak, Anna, et al.
Publicado: (2012)

Clinical validation and diagnostic accuracy of (99m)Tc-EDDA/HYNIC-TOC compared to (111)In-DTPA-octreotide in patients with neuroendocrine tumours: the LACOG 0214 study
por: Moriguchi-Jeckel, Cristina M, et al.
Publicado: (2023)

(99m)Tc-Glucarate for assessment of paclitaxel therapy in human ovarian cancer in mice
por: Sadeghi, Hossein, et al.
Publicado: (2018)

Glucagon-Like Peptide-1 Receptor Imaging with [Lys(40)(Ahx-HYNIC-(99m)Tc/EDDA)NH(2)]-Exendin-4 for the Diagnosis of Recurrence or Dissemination of Medullary Thyroid Cancer: A Preliminary Report
por: Pach, D., et al.
Publicado: (2013)

(99m)Tc-Hynic-TOC imaging in the diagnostic of neuroendocrine tumors
por: Liepe, Knut, et al.
Publicado: (2018)

Evaluation of a (99m)Tc-tricine Vascular Disrupting Agent as an In-vivo Imaging in 4T1 Mouse Breast Tumor Model
por: Erfani, Mostafa, et al.
Publicado: (2017)

Clinical usefulness of (99m)Tc-HYNIC-TOC, (99m)Tc(V)-DMSA, and (99m)Tc-MIBI SPECT in the evaluation of pituitary adenomas
por: Vukomanovic, Vladimir R., et al.
Publicado: (2019)

Effect of using different co-ligands during (99m)Tc-labeling of J18 peptide on SK-MES-1 cell binding and tumor targeting
por: Hosseinimehr, Seyed Jalal, et al.
Publicado: (2021)

Patient-specific dosimetry of (99m)Tc-HYNIC-Tyr(3)-Octreotide in children
por: Hou, Xinchi, et al.
Publicado: (2017)

Evaluation of Radiation dosimetry of (99m)Tc-HYNIC-PSMA and imaging in prostate cancer
por: Zhang, Jianping, et al.
Publicado: (2020)

(99m)Tc-Labeled HYNIC-DAPI Causes Plasmid DNA Damage with High Efficiency
por: Kotzerke, Joerg, et al.
Publicado: (2014)

A novel molecular imaging probe [(99m)Tc]Tc-HYNIC-FAPI targeting cancer-associated fibroblasts
por: Jiang, Yanghongyan, et al.
Publicado: (2023)

Data on the in vitro and in vivo anti-tumor effects of itraconazole, paclitaxel, and the two in combination in HT-29 and YM-1 cancer cell line and HT-29 colon cancer xenograft models
por: Ghadi, Mahdi, et al.
Publicado: (2021)

(99m)Tc-HYNIC-Annexin A5 in Oncology: Evaluating Efficacy of Anti-Cancer Therapies
por: Schaper, Frédéric L.W.V.J., et al.
Publicado: (2013)

Value of Somatostatin Receptor Scintigraphy with (99m)Tc-HYNIC-TOC in Patients with Primary Sjögren Syndrome
por: Anzola, Luz Kelly, et al.
Publicado: (2019)

Author Correction: Evaluation of Radiation dosimetry of (99m)Tc-HYNIC-PSMA and imaging in prostate cancer
por: Zhang, Jianping, et al.
Publicado: (2020)

Diagnostic accuracy of (99m)Tc-HYNIC-TOC SPECT/CT for detecting osteomalacia-associated tumors
por: Li, Bo, et al.
Publicado: (2023)

Evaluation of (99m)Tc-HYNIC-βAla-Bombesin((7-14)) as an agent for pancreas tumor detection in mice
por: Carlesso, F.N., et al.
Publicado: (2015)

Edda menor
Publicado: (1984)

Edda Mayor
Publicado: (1986)

Radionuclide Imaging of Apoptosis in Malignancies: Promise and Pitfalls of (99m)Tc-Hynic-rh-Annexin V Imaging
por: Kartachova, M.S., et al.
Publicado: (2008)

In-Vivo Biodistribution and Safety of (99m)Tc-LLP2A-HYNIC in Canine Non-Hodgkin Lymphoma
por: Zwingenberger, Allison L., et al.
Publicado: (2012)

Synthesis and Optimization of the Labeling Procedure of (99m)Tc-Hynic-Interleukin-2 for In vivo Imaging of Activated T lymphocytes
por: D’Alessandria, Calogero, et al.
Publicado: (2009)

EDB Fibronectin-Specific SPECT Probe (99m)Tc-HYNIC-ZD2 for Breast Cancer Detection
por: Ye, Xiao-Xuan, et al.
Publicado: (2017)

Tricin and tricin‐lignins in Medicago versus in monocots
por: Ralph, John
Publicado: (2020)

(99m)Tc-labelled S-HYNIC certolizumab pegol in rheumatoid arthritis and spondyloarthritis patients: a biodistribution and dosimetry study
por: Lambert, Bieke, et al.
Publicado: (2016)

Multiple Cutaneous Metastases on (99m)TC-HYNIC-TOC Scan in a Rare Case of Malignant Laryngeal Paraganglioma
por: Sankar, Gowri, et al.
Publicado: (2018)

Evaluation of (99m)Tc-HYNIC-MPG as a novel SPECT radiotracer to detect EGFR-activating mutations in NSCLC
por: Xiao, Zunyu, et al.
Publicado: (2017)

A 3D Monte Carlo Method for Estimation of Patient-specific Internal Organs Absorbed Dose for (99m)Tc-hynic-Tyr(3)-octreotide Imaging
por: Momennezhad, Mehdi, et al.
Publicado: (2016)

In vivo(99m)Tc-HYNIC-annexin V imaging of early tumor apoptosis in mice after single dose irradiation
por: Guo, Ming-fang, et al.
Publicado: (2009)

Preparation and Bioevaluation of Novel (99m)Tc-Labeled Complexes with a 2-Nitroimidazole HYNIC Derivative for Imaging Tumor Hypoxia
por: Ruan, Qing, et al.
Publicado: (2021)

Diagnostic performance of 99mTc-HYNIC-PSMA SPECT/CT for biochemically recurrent prostate cancer after radical prostatectomy
por: Li, Bo, et al.
Publicado: (2022)

SPECT Imaging with Tc-99m-Labeled HYNIC-FAPI-04 to Extend the Differential Time Window in Evaluating Tumor Fibrosis
por: Luo, Xiu, et al.
Publicado: (2023)

The efficacy of (99m)Tc-HYNIC-PSMA SPECT/CT in detecting primary lesions and metastasis in newly diagnosed prostate cancer
por: Wang, Taisong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nji3jo7357rn7p8ghilplan9l6